AI scans could predict lung trouble in scleroderma patients

NCT ID NCT06472362

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Royal Brompton & Harefield NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 28 times

Summary

This study looks at whether artificial intelligence can help predict how lung disease will progress in people with systemic sclerosis (scleroderma). Researchers will analyze CT scans from 1000 patients to see if certain patterns in the lungs can forecast worsening disease, development of pulmonary hypertension, and survival. The goal is to improve early detection and treatment planning.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Bichat-Claude Bernard hospital

Paris, France
Hanover Medical School

Hanover, Germany
Leeds Hospital/University of Leeds

Leeds, United Kingdom
Marche Polytechnic University

Ancona, Italy
Royal Brompton Hospital

London, United Kingdom
Sassari University

Sassari, Italy
Siena University Hospital

Siena, Italy

Conditions

Explore the condition pages connected to this study.

SYSTEMIC SCLEROSIS SYSTEMIC SCLEROSIS